Solvonis Therapeutics plc (LON:SVNS)
London · Delayed Price · Currency is GBP · Price in GBX 0.2960
+0.0260 (9.63%)
At close: Jan 23, 2026
Solvonis Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
3
Market Cap
20.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 587.00K | 45.00K | 8.30% |
| Dec 31, 2022 | 542.00K | 166.57K | 44.37% |
| Dec 31, 2021 | 375.43K | -144.57K | -27.80% |
| May 31, 2021 | 520.00K | 190.00K | 57.58% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Melrose Industries | 3.45B |
| Smiths Group | 2.92B |
| The Weir Group | 2.49B |
| IMI plc | 2.20B |
| Spirax Group | 1.66B |
| Morgan Advanced Materials | 1.05B |
| Rotork | 760.33M |
| Bodycote | 727.10M |